IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intercept Pharmaceut

CUSIP: 45845P10 | 4 institutional holders

Quarters

Q3 2016Q2 2016Q2 2015Q2 2014Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile